Shares of Organovo Holdings Inc. (ONVO), which soared over 240% yesterday, following a deal with Eli Lilly and Co. (LLY) are up another 18% in premarket trading today, reaching $1.50.
Organovo's FXR program, including its lead asset, FXR314, is all set to be acquired by Lilly. Under this transaction, Organovo will receive an upfront cash payment equal to $10.0 million and potential milestone payments of up to $50.0 million in the aggregate, which are contingent upon the achievement of certain development, regulatory, and commercial milestones. Lilly is acquiring all commercial and intellectual property rights to Organovo's FXR program for worldwide development.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.